Pancreatic mass
Conditions
Interventions
Gold Standard:follow-up or pathology
Sponsors
Fudan University Shanghai Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1.Age > 18 years old, both males and females are eligible; 2.Patients who underwent radial EUS examination and had pancreatic space-occupying lesions detected between January 2012 and April 2024; 3.Have complete EUS scanning images or electronic video files; 4.Further biopsies (EUS, CT, or intraoperative) or surgeries were conducted to obtain a definitive pathological diagnosis; 5.For suspected benign diseases, follow-up for more than 1 year is required, with the lesion showing regression or no progression, and no clinical evidence of malignancy; 6.Pathological diagnoses include, but are not limited to, the following: pancreatic ductal adenocarcinoma, inflammatory pancreatic mass, pancreatic neuroendocrine tumor, solid pseudopapillary tumor of the pancreas, intraductal papillary mucinous neoplasm of the pancreas, mucinous cystic tumor of the pancreas, serous cystadenoma of the pancreas, metastatic cancer to the pancreas, ectopic spleen in the pancreas, etc.
Exclusion criteria
Exclusion criteria: Unable to provide clear images for the identification of the lesion area according to the standard.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;specificity;accuracy;AUC; | — |
Countries
China
Contacts
Public ContactYu Xianjun
Fudan University Shanghai Cancer Center
Outcome results
None listed